Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon

Journal of Biomedical Materials Research

Volumn 35, Issue 1, 1997, Pages 81-92

  Tengvall, Pentti ^a   Askendal, Agneta ^a   Lundström, Ingemar ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; ELLIPSOMETRY; ENZYME IMMOBILIZATION; IMMUNOLOGY; SILICON;

ELLIPSOMETRY ANTIBODY TECHNIQUES; ENZYME LINKED IMMUNOSORBENT ASSAY TECHNIQUES; HUMAN COLOSTRUM IMMUNOGLOBULIN;

ANTIBODIES;

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; COMPLEMENT FACTOR H; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROPERDIN; SILICON;

ANTIGEN BINDING; ARTICLE; COLOSTRUM; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEASUREMENT; SERUM;

BIOCOMPATIBLE MATERIALS; COLOSTRUM; COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY; COMPLEMENT C3B; COMPLEMENT C4; COMPLEMENT C4B; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MATERIALS TESTING; METHYLATION; PEPTIDE FRAGMENTS; PREGNANCY; SILICON; SURFACE PROPERTIES;

EID: 0031127587     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I     Document Type: Article

References (29)

1. J. M. Austyn and J. J. Wood, "Inflammatory mediators and soluble effector mechanisms," in Principles of Cellular and Molecular Immunology, Oxford University Press, Oxford, UK, 1994, Chpt. 9.
2. G. Jahns, N. Haeffner-Cavaillon, U. E. Nydegger, and M. D. Kasatchkine, "Complement activation and cytokine production as consequences of immunological biocompatibility of extracorporeal circuits," Clin. Mater., 14, 303-336 (1993).
3. H. J. Müller-Eberhard, "Complement: Chemistry and pathways," in Inflammation, Basic Principles and Clinical Correlations, J. I. Gallin, I. M. Goldstein, and R. Snyderman (eds.), Raven Press, New York, 1988, pp. 21-53.
4. S. K. A. Law and K. B. M. Reid, "Role of complement in health and disease," in Complement, D. Male (ed.), IRL Press, in association with the British Society for Immunology, Oxford, UK, 1988.
5. P. W. Dempsey, M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon, "C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity," Science, 271, 348-350 (1996).
6. V. D. Miletic and M. M. Frank, "Complement-immunoglobulin interactions," Curr. Opin. Immunol, 7, 41-47 (1995).
7. P. J. Lachmann and N. C. Hughes-Jones, "Initiation of complement activation," in Complement, H. J. MüllerEberhard and P. A. Miescher (eds.), Springer-Verlag, Berlin, 1985, pp. 147-167.
8. A. K. Cheung, C. J. Parker, L. A. Wilcox, and J. fanatova, "Activation of complement by haemodialysis membranes: Polyacetonitrile binds more C3a than cuprophane," Kidney Int., 37, 1055-1059 (1990).
9. M. D. Kazatchkine, D. T. Fearon, J. E. Silbert, and K. F. Austen, "Surface-associated heparin inhibits zymozan-induced activation of the human alternative pathway by augmenting the regulatory action of the control proteins on particle-bound C3b," J. Exp. Med., 130, 1202-1215 (1979).
10. M. P. Carreno, D. Labarre, M. Jozefowicz, and M. D. Kazatchkine, "The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives," Mol. Immunol., 25, 165-171 (1988).
11. B. Montdargent, F. Maillet, M. P. Carreno, M. Jozefowitz, M. Kazatchkine, and D. Labarre, "Regulation by sulphone groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces," Biomaterials, 14, 203-208 (1993).
12. U. R. Nilsson, O. Larm, B. Nilsson, K.-E. Storm, H. Elwing, and K. Nilsson-Ekdal, "Modification of the complement binding properties of polystyrene: Effects of end-point heparin attachment," Scand. J. Immunol., 37, 349-354 (1993).
13. N. R. Cooper, G. R. Nemerow, and J. T. Mayes, "Methods to detect and quantitate complement activation," in Complement, H. J. Müller-Eberhard and P. A. Miescher (eds.), Springer-Verlag, Berlin, 1985, pp. 455-472.
14. H. Elwing, B. Ivarsson, and I. Lundström, "Complement deposition from human sera on silicon surfaces studied in situ by ellipsometry: The influence of surface wettability," Eur. J. Biochem., 156, 359-365 (1986).
15. L. Liu and H. Elwing, "Complement activation on solid surfaces as determined by C3 deposition and hemolytic consumption," J. Biomed. Mater. Res., 28, 767-773 (1994).
16. P. Tengvall, A. Askendal, and I. Lundström, "Complement activation by 3-mercapto-1,2-propanediol immobilized on gold surfaces," Biomaterials, 17, 1001-1007 (1996).
17. P. S. Hiemstra, A. Gorter, M. E. Stuurman, L. van Es, and M. R. Daha, "Activation of the alternative pathway of complement by human serum IgA," Eur. J. Immunol, 17, 321 (1987).
18. J. M. Austyn and K. J. Wood, "Principles of cellular and molecular immunology," in Complement, Oxford University Press, Oxford, UK, 1993, pp. 522-554.
19. P. Tengvall, A. Askendal, and I. Lundström, "Complement activation by IgG immobilized on methylated silicon," J. Biomed. Mater. Res., 31, 305-311 (1996).
20. W. Kern, and D. A. Puotinen, "Cleaning solutions based on hydrogen peroxide for use in silicon semiconductor technology," RCA Review, 187-206 (1970).
21. F. L. McCrackin, National Bureau of Standards Technical Note No. 479, Washington, DC, 1969.
22. J. A. de Fejter, J. Benjamins, and F. A. Veer, "Ellipsometry as a tool to study the adsorption of synthetic and biopolymers at the air-water interface," Biopolymers, 17, 1759-1801 (1978).
23. M. K. Pangburn, R. D. Schreiber, and H. J. Eberhard-Müller, "C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface," J. Immunol., 131, 1930 (1983).
24. P. J. Lachmann and L. Halbwachs, "The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation," Clin. Exp. Immunol, 21, 109 (1975).
25. D. T. Fearon and K. F. Austen, "Properdin: Binding to C3b and stabilization of the C3b-dependent C3 convertase," J. Exp. Med., 142, 856-863 (1975).
26. J. Chaipitis and I. H. Lepow, "Multiple sedimenting species of properdin in human serum and interaction of human purified properdin with the third component of complement," J. Exp. Med., 143, 241-257 (1976).
27. T. C. Farries, J. T. Finch, P. J. Lachmann, and R. A. Harrison, "Resolution and analysis of 'native' and 'active' properdin," Biochem. J., 243, 507-517 (1987).
28. Z. Fishelson and H. J. Müller-Eberhard, "C3 convertase of human complement: Enhanced formation and stability of enzyme generated with nickel instead of magnesium," J. Immunol., 129, 2603-2607 (1982).
29. W. D. Rarnoff, D. T. Fearon, and K. F. Austen, "The role of antibody in the activation of the alternative complement pathway," in Springer Seminars in Immunopathology 6, Springer Verlag, 1983, pp. 361-371.